Jan 2024

Expertise of the month

Expertise of the month: Identification of a sustainable route for faster and cheaper development

Due to the time or budget constraints, process development is often underestimated at the early development phases, slowing down and jeopardizing high-value projects. At SpiroChem, thanks to our in-depth understanding of drug development challenges, we recommend and offer Early Route Scouting that guarantees smoother, safer, faster and more cost-effective scale-up from pre-clinical studies, paving the way for clinical development and market.

Classical way with short-term benefits

The MedChem route:

is never really questioned
is felt to be fit-for-purpose and developing it to be a lower risk

The short-term benefits:

consist of putting just about enough FTEs for quick fixes
don’t preclude longer term risks at the most time-critical part
of your clinical development

Do you want to avoid:

supply delays at the most time-critical stage of your clinical development?
refiling for regulatory submissions because of a necessary late-stage
synthetic route change?

The way to go with long-term benefits

The earlier a robust route is designed and developed, the shorter the overall time and the lesser the investments until process validation and registration.

SpiroChem helps you to be prepared to ensure:

Smooth scale-up from GLP-Tox batches to GMP batches
No disruptions from discovery to market

Save time and money for your project by investing early in Route Scouting at SpiroChem.

Back to all